Beruflich Dokumente
Kultur Dokumente
Base Year: April 2011 to 2012 (FY 12) Market Forecast: FY 12 to FY 17 Currency: Rs. The market has been classified as below Regional Classification
Product Categorization
Large (More Than INR 1000 Crores) Medium (INR 500-1000 Crores) Small (Less Than INR 500 Crores)
2 |
Section 1 to 3
Section 1: Background
Scope of this research Research aim and objectives
Research methodology
3 |
Section 4 to 6
4 |
Section 7 to 9
5 |
List of Charts
1. Price chart 2. All India pharmaceutical market 2012 (value) 3. Market size by product categories 2012
4.
5. 6. 7. 8. 9. 10. 11. 12.
(value) Market size by product categories 2012 (volume) Market size by players 2012 (value) Market size by players 2012 (volume) Market size by segments (value) Market size by segments (volume) Market size by regions (value) Market size by regions (volume) Market forecast by segments (volume) New investments planned (value)
Abbott India Ltd Ranbaxy Dr. Reddys Laboratories Lupin Ltd Aurobindo Pharma Dabur Sun Pharmaceutical Cadila Healthcare Jubliant Lifescience Piramal Healthcare
6 |
Report Cost
Electronic Copy (PDF format): INR XXX + Service Tax Electronic Copy (PPT format): INR XXX + Service Tax
7 |
This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices. In depth market scenario includes current market size estimates, including domestic market, imports and exports and market splits by players. Market structure details the player categories, key players presence across products and end user segments. Market practices include understanding the Indian Pharmaceutical business, market trends, distribution practices and pricing The report also provides a snapshot of key competition, past market trends with forecast over the next 5 years, anticipated growth rates and the principal factors driving and impacting growth Market data and analytics are derived from a combination of primary and secondary sources
8 |
The market values and volumes are order of magnitude estimates, based on discussions with stakeholders Qualitative information is based primarily on discussions held with the key players and could therefore be subject to variations Study of individual user segments is excluded from the scope of this research Forecasts are based on current prices and have not factored in inflation, any changes in duty structures, etc.
9 |
All Rights Reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, Feedback Business Consulting Services Pvt. Limited. The information contained herein has been obtained from sources believed to be reliable. Feedback Business Consulting disclaims all warranties as to the accuracy, completeness or adequacy of such information. Feedback Business Consulting shall have no liability for errors, omissions or inadequacies in the information contained herein, or for interpretations thereof
10 |